Glaukos Corporation

United States
Total Offices: 10
1,094 Total Employees
Year Founded: 1998
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It pioneered micro-invasive glaucoma surgery and commercializes surgical devices and procedural pharmaceuticals, including the iStent and iDose TR. The company also provides FDA-approved corneal cross-linking technology for progressive keratoconus and continues building a portfolio of surgical and pharmaceutical therapies across eye care.

Glaukos Corporation Offices

Hybrid Workspace

Employees engage in a combination of remote and on-site work.

Typical time on-site:
United States
Canada
United Kingdom
Germany
Japan
Australia
Brazil
France
Ireland
Netherlands